{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:41Z","timestamp":1792098581964,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jacc.2019.09.057","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T13:58:29Z","timestamp":1574690309000},"page":"2799-2811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["Primary Aldosteronism"],"prefix":"10.1016","volume":"74","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.09.057_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor","volume":"16","author":"Rossi","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-44-1-1","article-title":"Primary aldosteronism, a new clinical entity","volume":"44","author":"Conn","year":"1956","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","article-title":"Primary aldosteronism: an update on screening, diagnosis and treatment","volume":"26","author":"Rossi","year":"2008","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11906-007-0017-3","article-title":"New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism","volume":"9","author":"Rossi","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2019.09.057_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2006.07.003","article-title":"Surgically correctable hypertension caused by primary aldosteronism","volume":"20","author":"Rossi","year":"2006","journal-title":"Best Pract Res Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-003-0012-2","article-title":"Aldosterone: a risk factor for vascular disease","volume":"5","author":"Fritsch","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2019.09.057_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0029-1243253","article-title":"Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists","volume":"42","author":"Schupp","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jacc.2019.09.057_bib9","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha R, Jr. CTS","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacc.2019.09.057_bib10","doi-asserted-by":"crossref","first-page":"H813","DOI":"10.1152\/ajpheart.00113.2003","article-title":"Aldosteronism: an immunostimulatory state precedes proinflammatory\/fibrogenic cardiac phenotype","volume":"285","author":"Gerling","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib11","first-page":"S87","article-title":"Myocardial fibrosis and the concepts of cardioprotection and cardioreparation","volume":"10","author":"Weber","year":"1992","journal-title":"J\u00a0Hypertens Suppl"},{"key":"10.1016\/j.jacc.2019.09.057_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-004-0001-0","article-title":"Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?","volume":"6","author":"Rossi","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2019.09.057_bib13","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib14","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians","volume":"34","author":"Mulatero","year":"2016","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib16","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jacc.2017.02.041","article-title":"The time has come for systematic screening for primary aldosteronism in all hypertensives","volume":"69","author":"Maiolino","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","article-title":"Normokalemic primary aldosteronism. a detectable cause of curable \u201cessential\u201d hypertension","volume":"193","author":"Conn","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.09.057_bib18","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1097\/HJH.0000000000000748","article-title":"Normoaldosteronemic aldosterone-producing adenoma: Immunochemical characterization and diagnostic implications","volume":"33","author":"Rossi","year":"2015","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/HYPERTENSIONAHA.113.02989","article-title":"Renin-angiotensin-aldosterone system racial differences in sensitivity of blood pressure to aldosterone","volume":"63","author":"Tu","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.114.03127","article-title":"Sensitivity to aldosterone","volume":"63","author":"Funder","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360600931831","article-title":"Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension","volume":"44","author":"Rossi","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jacc.2019.09.057_bib22","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib23","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib24","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/01.hjh.0000523080.65085.08","article-title":"Frequency of primary aldosteronism in patients with obstructive sleep apnea\u2014OSA-PA study","volume":"35 e-Suppl 2","author":"Karcz","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib25","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/jhh.2013.32","article-title":"Clinical characteristics of patients with resistant hypertension: the RESIST-POL study","volume":"27","author":"Florczak","year":"2013","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/jhh.2017.28","article-title":"Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea","volume":"31","author":"Wolley","year":"2017","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1161\/01.HYP.27.5.1153","article-title":"Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats","volume":"27","author":"Belloni","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/HYPERTENSIONAHA.116.08956","article-title":"Arterial hypertension, atrial fibrillation, and hyperaldosteronism: the triple trouble","volume":"69","author":"Seccia","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib29","article-title":"Atrial fibrillation as presenting sign of primary aldosteronism: results of the PAPPHY Study","author":"Seccia","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Primary aldosteronism continuum of renin-independent aldosteronism in normotension","volume":"68","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib31","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.09.057_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib33","first-page":"1","article-title":"Long term outcome of aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2019.09.057_bib34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib36","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A\u00a0screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib37","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/HJH.0b013e32833d2192","article-title":"The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma","volume":"28","author":"Rossi","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrendo.2011.76","article-title":"A\u00a0comprehensive review of the clinical aspects of primary aldosteronism","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacc.2019.09.057_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","article-title":"Within-patient reproducibility of the aldosterone:renin ratio in primary aldosteronism","volume":"55","author":"Rossi","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib40","article-title":"Quantitative value of aldosterone-renin ratio for detection of aldosterone-producing adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) study","volume":"6","author":"Maiolino","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.09.057_bib41","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2019.09.057_bib42","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2015-1094","article-title":"Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension","volume":"54","author":"Rossi","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.1998.00608.x","article-title":"Screening for primary aldosteronism with a logistic multivariate discriminant analysis","volume":"49","author":"Rossi","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2019.09.057_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.patrec.2015.07.023","article-title":"Heterogeneous machine learning system for improving the diagnosis of primary aldosteronism","volume":"65","author":"Lazzarini","year":"2015","journal-title":"Pattern Recognit Lett"},{"key":"10.1016\/j.jacc.2019.09.057_bib45","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/HJH.0000000000000892","article-title":"A\u00a0useful tool to improve the case detection rate of primary aldosteronism: the aldosterone-renin ratio (ARR)","volume":"34","author":"Rossi","year":"2016","journal-title":"App J Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.2018-01299","article-title":"Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism","volume":"104","author":"Nanba","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib47","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","article-title":"Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy","volume":"99","author":"Haase","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41371-018-0139-x","article-title":"Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone\u2013renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design","volume":"33","author":"Rossitto","year":"2018","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib49","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","article-title":"Resistant hypertension: detection, evaluation, and management a scientific statement from the American Heart Association","volume":"72","author":"Carey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib50","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.09.057_bib51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/HJH.0000000000001671","article-title":"Effect of MRAs on blood pressure lowering: overview and meta-analysis of randomized controlled trials in hypertension","volume":"36","author":"Bazoukis G TC. TC","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib52","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Gguidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.09.057_bib53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","article-title":"Reliability of screening methods for the diagnosis of primary aldosteronism","volume":"67","author":"Streeten","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib55","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib56","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/ajh\/4.9.786","article-title":"Reassessment of the predictive value of the postural stimulation test in primary aldosteronism","volume":"4","author":"Fontes","year":"1991","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib57","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajh\/3.7.576","article-title":"Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma","volume":"3","author":"Irony","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1440-1681.1986.tb00357.x","article-title":"Distinguishing aldosterone-producing adenoma from other forms of hyperaldosteronism and lateralizing the tumor pre-operatively","volume":"13","author":"Gordon","year":"1986","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib59","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1210\/jcem.85.12.7086","article-title":"Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma","volume":"85","author":"Phillips","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib60","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrendo.2011.180","article-title":"Adrenal gland: a diagnostic algorithm\u2014the holy grail of primary aldosteronism","volume":"7","author":"Rossi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacc.2019.09.057_bib61","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1042\/CS20171593","article-title":"The angiotensin type 2 receptor in the human adrenocortical zona glomerulosa and in aldosterone-producing adenoma: low expression and no functional role","volume":"132","author":"Vanderriele","year":"2018","journal-title":"Clin Sci"},{"key":"10.1016\/j.jacc.2019.09.057_bib62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","article-title":"Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn\u2019s syndrome with an ominous clinical course","volume":"12","author":"Seccia","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jacc.2019.09.057_bib63","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.jacc.2019.09.057_bib64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib65","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib66","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/eci.12746","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism","author":"Ladurner","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2019.09.057_bib67","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/jc.2018-02089","article-title":"Discordance between imaging and adrenal vein sampling in primary aldosteronism irrespective of interpretation criteria","volume":"104","author":"Sam","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib68","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib69","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/HJH.0000000000001939","article-title":"10 good reasons why adrenal vein sampling is the preferred method for referring primary aldosteronism patients for adrenalectomy","volume":"37","author":"Rossi","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jacc.2019.09.057_bib70","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MED.0000000000000407","article-title":"Update in adrenal venous sampling for primary aldosteronism","volume":"25","author":"Rossi","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jacc.2019.09.057_bib71","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A\u00a0clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"Kupers","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cen.12374","article-title":"Diagnosing unilateral primary aldosteronism\u2013comparison of a clinical prediction score, computed tomography and adrenal venous sampling","volume":"81","author":"Sze","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2019.09.057_bib73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4330\/wjc.v6.i5.227","article-title":"Management of hypertension in primary aldosteronism","volume":"6","author":"Aronova","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacc.2019.09.057_bib74","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metamidate positron emission tomography (PET) -CT for lateralizing aldosterone secretion by Conn's adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib75","first-page":"483","article-title":"C-metomidate PET-CT scanning can identify aldosterone-producing adenomas after unsuccessful lateralisation with CT\/ MRI and adrenal venous sampling","volume":"31","author":"Ouyang","year":"2017"},{"key":"10.1016\/j.jacc.2019.09.057_bib76","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/cen.13942","article-title":"11C-metomidate PET\/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice","volume":"90","author":"Joyce","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jacc.2019.09.057_bib77","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib78","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A\u00a0novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib79","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jacc.2019.09.057_bib80","first-page":"553","article-title":"Glucocorticoid-remediable aldosteronism","volume":"21","author":"Litchfield","year":"1995","journal-title":"Compr Ther"},{"key":"10.1016\/j.jacc.2019.09.057_bib81","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/0003-4819-116-10-813","article-title":"Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype","volume":"116","author":"Rich","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2019.09.057_bib82","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1210\/en.2016-1170","article-title":"CACNA1H(M1549V) mutant calcium channel causes autonomous aldosterone production in HAC15 Cells and is inhibited by mibefradil","volume":"157","author":"Reimer","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.jacc.2019.09.057_bib83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2019.09.057_bib84","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2019.09.057_bib85","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/HYPERTENSIONAHA.118.11150","article-title":"Saga of familial hyperaldosteronism: yet a new channel","volume":"71","author":"Lenzini","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib86","doi-asserted-by":"crossref","first-page":"E1124","DOI":"10.3390\/ijms19041124","article-title":"Comparative genomics and transcriptome profiling in primary aldosteronism","volume":"19","author":"Prada","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacc.2019.09.057_bib87","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib88","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A\u00a0meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib89","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib90","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"72","author":"Meyer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib92","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI91733","article-title":"Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma","volume":"127","author":"Scholl","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2019.09.057_bib93","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/HYPERTENSIONAHA.117.10226","article-title":"Macrolides blunt aldosterone biosynthesis: a proof-of-concept study in KCNJ5 mutated adenoma cells ex\u00a0vivo","volume":"70","author":"Caroccia","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib94","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/08037051.2018.1436961","article-title":"Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism","volume":"27","author":"Maiolino","year":"2018","journal-title":"Blood Press"},{"key":"10.1016\/j.jacc.2019.09.057_bib95","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF03347198","article-title":"Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients","volume":"28","author":"Iacobone","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.jacc.2019.09.057_bib96","article-title":"Clinical outcomes after unilateral adrenalectomy for primary aldosteronism","volume":"154","author":"Talutis","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jacc.2019.09.057_bib97","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12893-018-0432-1","article-title":"Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism","volume":"18","author":"Citton","year":"2019","journal-title":"BMC Surg"},{"key":"10.1016\/j.jacc.2019.09.057_bib98","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"The clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib99","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/SLE.0b013e3182270b0a","article-title":"Robot-assisted adrenalectomy","volume":"21","author":"Brunaud","year":"2011","journal-title":"Surg Laparosc Endosc Percutaneous Tech"},{"key":"10.1016\/j.jacc.2019.09.057_bib101","first-page":"1","article-title":"A\u00a0novel method: super-selective adrenal venous sampling","volume":"2","author":"Makita","year":"2017","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jacc.2019.09.057_bib102","first-page":"1578","article-title":"Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"185","author":"Fu","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jacc.2019.09.057_bib103","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1148\/radiol.2272011798","article-title":"Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases","volume":"227","author":"Hokotate","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2019.09.057_bib104","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/msy.1998.93108","article-title":"Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?","volume":"124","author":"Proye","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.jacc.2019.09.057_bib105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacc.2019.09.057_bib106","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib107","first-page":"987","article-title":"Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism","volume":"112","author":"Obara","year":"1992","journal-title":"Surgery"},{"key":"10.1016\/j.jacc.2019.09.057_bib108","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2019.09.057_bib109","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/jc.2016-3867","article-title":"Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity","volume":"102","author":"Hundemer","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib110","article-title":"New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure","author":"Capelli","year":"2019","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jacc.2019.09.057_bib111","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A\u00a0number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ejhf.444","article-title":"Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease","volume":"18","author":"Bramlage","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.09.057_bib113","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","article-title":"Aldosterone synthase inhibition with LCI699","volume":"56","author":"Amar","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib114","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/HYPERTENSIONAHA.117.09991","article-title":"Review of markers of zona glomerulosa and aldosterone-producing adenoma cells","volume":"70","author":"Seccia","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2019.09.057_bib115","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(00)03129-9","article-title":"A\u00a0thoracic mass with hypertension and hypokalaemia","volume":"356","author":"Rossi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2019.09.057_bib116","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2019.09.057_bib117","doi-asserted-by":"crossref","first-page":"I183","DOI":"10.1161\/01.HYP.6.2_Pt_2.I183","article-title":"Role of renal hemodynamics and arterial pressure in aldosterone \u201cescape.\u201d","volume":"6","author":"Hall","year":"1984","journal-title":"Hypertension"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719379276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719379276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:25:55Z","timestamp":1760016355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719379276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":117,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0735109719379276"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.09.057","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier on behalf of the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}